Navigation Links
24th Annual EAU Congress highlights many new developments
Date:2/5/2009

give the Socit Internationale d'Urologie lecture 'Castration resistant prostate cancer: New therapeutic approaches'. Advanced prostate cancer has high initial response rates to androgen ablation. However, remissions are temporary because surviving tumour cells usually progress to castrate-refractory prostate cancer. Dr. Gleave will be discussing the status of several novel agents in clinical trials either as single agents or in combination with cytotoxic chemotherapy, including the androgen receptor, endothelin receptor, and molecular chaperones.

Dr. Smith from Boston (U.S.) is keen on presenting the exciting results of his trial (A randomized, double-blind, placebo-controlled trial of denosumab in men receiving androgen deprivation therapy for non-metastatic prostate cancer) from 10:25 to 10:55 hours as part of the 'The best EAU papers' session.

According to Dr. Johann de Bono from London (UK), who will be presenting 'New approaches to target androgen receptors in prostate cancer' from 11:45 to 12:00 hours, there is now incontrovertible evidence that what we have previously defined as hormone refractory prostate cancer is a disease that remains steroid hormone drive. Clinical evidence is now available that novel agents targeting androgen synthesis and more potent androgen receptor antagonists have significant antitumor activity. He will be reporting about trials with these novel agents.

On Saturday, 21 March, Professor Fritz Schrder from Rotterdam (NL) will be giving an important update on the European Randomised Study of Screening for Prostate Cancer (ERSPC) from 11:15 to 11:35 hours. The ERSPC is a large European study involving 8 countries (Belgium, Finland, France, Italy, Sweden, Spain, Switzerland and the Netherlands). This presentation will, for the first time, summarise results obtained by all centres.

More information about the new initiative 'EAU TV', the Meet-the-Expert sessions and the EAU Press Conference which wil
'/>"/>

Contact: Lindy Brouwer
l.brouwer@uroweb.org
31-263-890-680
European Association of Urology
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Three-Time Grammy Nominee Raphael Saadiq to Perform at 17th Annual Elton John AIDS Foundation Academy Awards(R) Viewing Party
2. AUA Annual Scientific Meeting features more new research than ever before
3. Healthy Humor & Laughter are in the Cards at the 22nd Annual Association for Applied and Therapeutic Humor Conference
4. GBC Seeks Nominations for Fourth Annual Bioscience Awards
5. Video: Celebrities and Professional Athletes Invite the Public to Join them at the Third Annual National Walk for Epilepsy on March 28, in Washington, D.C.
6. Cadient Interactives Will Reese to Discuss Strategies for Engaging Physicians Online at Eighth Annual ePharma Summit
7. Align Technology Executives to Present at ROTH 21st Annual OC Growth Stock Conference
8. Elder Abuse Prevention the Focus of Wayne County Medical Society Foundations Annual Chinese New Year Fundraiser
9. VirtualScopics to Present at 11th Annual BIO CEO & Investor Conference
10. Michigan Dentists Giving Free Dental Care to Low-Income Children During Annual Give Kids a Smile Program Starting February 6
11. Sunstar to Support ADAs 60th Annual National Childrens Dental Health Month

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...tudy finds myriad microbes in tobacco, but risk is...y News) -- New research provides evidence that th...ing bacteria that cause respiratory disease. , ... out, the authors of the new study aren,t sure wha...bacteria is nothing new: Microbes surround us ever...
(Date:12/2/2009)..., Scientists may not be able to tell a good book ...of an old book by its smell. In a report in ACS, ...y describe development of a new test that can meas...orical documents based on their smell. The nondest...ums preserve a range of prized paper-based objects...
(Date:12/2/2009)..., , WASHINGTON, Dec. 2 Holl...al Media and Stakeholder Management for Kaiser Per...R News, PR People luncheon held at the National P...petition showcases the top innovators and professi...ions matter in the marketplace. The winners of thi...
(Date:12/2/2009)..., , Media Advisory for Thursday, Dec. 3 ,... Speak at Luncheon Meeting of Army Wounded Warrior...Helps Vets Adjust ,, WASHINGTON, Dec. 2 /PRNew...day by the National Organization on Disability: ,... from the Army Wounded Warrior (AW2) program,s Nat...
(Date:12/2/2009)...ouse study suggests the gene could be linked to li...HealthDay News) -- Sperm genes may affect life spa...in why females tend to live longer than males, Jap...hat mice created using two female genomes -- bi-ma... than mice created from the normal combination of ...
Breaking Medicine News(10 mins):Health News:Smokers Inhaling Germs With Each Cigarette 2Health News:Kaiser Permanente Public Relations Leader Wins PR People Award 2Health News:Kaiser Permanente Public Relations Leader Wins PR People Award 3Health News:Wounded Vets, CAREER Counselors Gather in Washington as Obama Announces Afghanistan Troop Buildup 2Health News:Sperm Gene May Cause Men's Longevity Disadvantage 2
...Scots are at a high risk of developing diabetics. ...s on the rise. Statistics show that in the next 25...uffer from diabetes. The Scottish Executives are ...measures. So far the number of people diagnose...
...Health Service Plans for the Northeast have been a...egional hospital is expected to be opened by 2015/...northeast are located in Dundalk, Drogheda, Navan,...lth care system in the region. The existing se...
...The Brihanmumbai Municipal Corporation’s (BMC) Hea...a medical team and conducted health camps// Chamun...ses of malnutrition have been reported. Their repo...ours later, found three children suffering from ma...
...A new study in the July 15 issue of Clinical Infec...s known as statins could be very useful// in the e...ly available. Statins lower "bad" cholestero...ucing inflammation. Recent studies suggest that th...
...Acting tough on the medicos who had resorted to th...stitutions, Health Minister Anbumani Ramadoss toda...e strike period was not a punishment. 'It is ...y medicos at the AIIMS for not getting their salar...
...The National Cadet Corps will soon sign an MoU wit...s on HIV and AIDS in India, Director General of NC...ed to be created among the HIV infected that there...ntrolling the spread of drug addiction would also ...
Other Medicine News:Health News:Children In Slums Of Mumbai Might be Suffering From Malnutrition 2Health News:Statins Could Play Important Role In Influenza Pandemic 2
(Date:12/2/2009)..., , EAST HANOVER, N.J., Dec. 2 /PR...a, including a late-breaking presentation on Tasig...chronic myeloid leukemia, demonstrate the strength...g the care of patients. ,, The new data, at th... Meeting and Exposition, highlight the company,s c...
(Date:12/1/2009)..., , NEW YORK, Dec . 1 /PRNewswire/ -...earch report is available in its catalogue: ,, ... ,, http://www.reportlinker.com/p0164247/Insul..., Insulin pumps, also called Continuous Subcutan...ol over diabetes, when compared to other forms of ...
(Date:12/1/2009)..., , NEW YORK, Dec. 1 /PRNewswire/ -...earch report is available in its catalogue: ,, ...eview ,, http://www.reportlinker.com/p0164366....html ,, Over the years, Liquid Chromatography...ences, pharmaceuticals, food and beverage, researc...
Breaking Medicine Technology:Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Reportlinker Adds Insulin Pumps (External) - A World Market Review 2Reportlinker Adds Insulin Pumps (External) - A World Market Review 3Reportlinker Adds Insulin Pumps (External) - A World Market Review 4Reportlinker Adds HPLC Systems & Accessories - A World Market Review 2Reportlinker Adds HPLC Systems & Accessories - A World Market Review 3Reportlinker Adds HPLC Systems & Accessories - A World Market Review 4Reportlinker Adds HPLC Systems & Accessories - A World Market Review 5Reportlinker Adds HPLC Systems & Accessories - A World Market Review 6Reportlinker Adds HPLC Systems & Accessories - A World Market Review 7Overweight kids experience more loneliness anxiety MU study finds 50660 1Overweight kids experience more loneliness anxiety MU study finds 50660 2Natural compound stops retinopathy 9106 1Ben Gurion U researchers reveal connection between cancer and human evolution 9104 1Ben Gurion U researchers reveal connection between cancer and human evolution 9104 2
...k Buyer for Marketed Parenteral Product Ganite(R),...ated,(Nasdaq: GNTA ) today announced that the Com...on covering novel pharmaceutical gallium compositi...ent Office. Issued U.S.,Patent 7,354,952 extends t... franchise of oral gallium-containing products tha...
...Developed and Validated Clinically at Clinical Lab...Laboratory at the University of Ca...cs Expects Three Tests Applying its MicroRNA Techn...ertified Labs During 2008, REHOVOT, Israel and JE... Ltd. (Nasdaq: ROSG ), a leader in,the development...
Other Medicine Technology:Genta Receives Key Patent Related to Oral Gallium Compound G4544 2Genta Receives Key Patent Related to Oral Gallium Compound G4544 3Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Company's MicroRNA Technology 2Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Company's MicroRNA Technology 3Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Company's MicroRNA Technology 4
Orrison's Medical Imaging Consultant for PDA
Schwartz Principles of Surgery PDA Edition
Sanford Guide to HIV/AIDS Therapy 2004
LyteMeister
Medicine Products: